ArticleBMC psychiatry2026
Effects of serum hypersensitive C-reactive protein and BMI on cognitive dysfunction in first-episode and drug-naive patients with major depressive disorder.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Gut microbiota alterations associated with anxiety and depression in inflammatory bowel disease: a systematic review of prospective cohorts and randomized trials.Frontiers in microbiology · 2026Pooled it
- Dissecting the Ecological Structure of Health and Disease in the Global Gut Microbiome.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Continuous Alterations in the Gut Microbial Landscape Associated With Suicidal Ideation in First-Episode Drug-naïve Major Depressive Disorder.CNS neuroscience & therapeutics · 2026Article
- Temporal dynamic brain-heart interaction alterations associated with suicidal ideation in major depressive disorder.BMC psychiatry · 2026Article
- Novel insights into gut microbiota alterations in major depressive disorder with suicidal ideation: a metagenomic analysis.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundMajor Depressive Disorder (MDD) is among the most prevalent psychiatric disorders worldwide, contributing substantially to global disease burden and disability. Besides its core symptoms, the cognitive dysfunction in MDD patients seriously impairs their social functioning and warrants attention. Cognitive dysfunction in MDD may be related to demographic characteristics, serum inflammatory indices levels and Body Mass Index (BMI, calculated as weight divided by height squared, in kg/m²). This study focuses on the cognitive dysfunction and its associated factors in first-episode, drug-naive patients with MDD.
methodsThe study enrolled overall 116 first-episode, drug-naive patients with MDD and 100 healthy controls (HC) for comparison. Demographic information was obtained from all participants. We used the Chinese version of the MATRICS Consensus Cognitive Battery (MCCB) to assess cognitive function and the 17-item Hamilton Depression Rating Scale (HAMD-17) to evaluate MDD symptoms. Levels of serum inflammatory indices, such as hypersensitive C-reactive protein (hs-CRP), leukocyte (WBC), neutrophil, and eosinophil were measured. Subsequently, multiple linear regression analysis was utilized to determine factors linked to cognitive dysfunction across the five domains with MDD patients.
resultsIn this study, MDD patients exhibited significantly poorer cognitive function across five domains - speed of processing (SOP), attention/vigilance (AV), working memory (WM), verbal learning (VIS), and visual learning (VRB) - compared with HC (p < 0.001). Their serum levels of hs-CRP (p = 0.022), WBC (p = 0.015), and neutrophil (p < 0.001) were significantly elevated than HC, whereas the level of eosinophil (p = 0.031) was significantly lower. The results of Spearman correlation analysis indicated that BMI was connected to cognitive function among MDD patients, specifically in the domains of SOP (r = 0.274, p = 0.003) and AV (r = 0.189, p = 0.042). Multiple linear regression analysis indicated that education years and hs-CRP level were significantly influenced by the cognitive function in the VIS domain among patients with MDD.
conclusionOur study shows a potential link between serum hs-CRP levels, BMI and cognitive dysfunction in MDD patients. This finding establish serum hs-CRP and BMI as robust, clinically accessible correlates of cognitive dysfunction in MDD, supporting their potential utility as complementary indicators for identifying patients at highest risk of cognitive impairment. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.